Navigation Links
The International Rett Syndrome Foundation Names Antony Horton Ph.D. Chief Scientific Officer
Date:6/2/2008

CINCINNATI, June 2 /PRNewswire/ -- The International Rett Syndrome Foundation announced today that Antony Horton Ph.D. will join the Foundation as Chief Scientific Officer, beginning July 1. Dr. Horton will oversee the foundation's research portfolio and its network of Rett Clinics, a series of clinics throughout the US with established neuromedical research and treatment centers. In addition, Dr. Horton will assist the IRSF Board of Directors in growing its funding pool and broadening its network of research partners. IRSF is the world's leading private funder of basic and clinical Rett syndrome research. IRSF was formed in 2007 by the merger of The International Rett Syndrome Association and the Rett Syndrome Research Foundation.

"Dr. Horton joins us during an exciting time for Rett syndrome research since recent breakthroughs give new insight into the function of the MECP2 gene that causes Rett syndrome and last year's discovery of the reversibility of Rett symptoms in mice models," said Kathryn Kissam, IRSF Board Chair. "We have the opportunity to fund crucial new research with the potential to impact lives and advance the understanding of Rett syndrome and related disorders. Dr. Horton's knowledge of the science of drug discovery and his experience in research program management will help the Foundation to shape and advance our mission of improving the lives of children living with Rett while searching for a cure to this devastating disease."

According to Dr. Horton, "As Chief Scientific Officer, I am eager to bring my scientific vision and research management experience to bear on the IRSF mission. I look forward to developing a portfolio of research programs that will accelerate translation of research discoveries into therapies to treat and cure Rett syndrome."

Dr. Horton earned his Ph.D. in developmental neurobiology at St. Andrew's University in Scotland. Currently, Dr. Horton is the Director of Scientific Affairs for the Alzheimer's Drug Discovery Foundation in New York. Previously, he served for several years as Program Director at the Juvenile Diabetes Research Foundation and as a post doctoral scientist at Rockefeller University Laboratory of Molecular Biology.

About Rett Syndrome

While there are over 3,800 known cases of Rett Syndrome in the United States which predominantly strikes only girls, the disorder is genetically linked to more widespread neurological disorders such as autism and schizophrenia. Rett symptoms begin to manifest between the first six to eighteen months of life and in most cases will eventually incapacitate the afflicted children so that they cannot survive without constant care. The disorder causes seizures, respiratory and gastrointestinal abnormalities, and a variety of muscular and motor impairments.

IRSF is the world's most comprehensive non-profit organization dedicated to providing thorough and accurate information about Rett syndrome, offering informational and educational family support, and stimulating research aimed at accelerating treatments and a cure for Rett syndrome. To learn more about IRSF and Rett syndrome, visit http://www.rettsyndrome.org or call IRSF at 1-800-818-RETT.


'/>"/>
SOURCE The International Rett Syndrome Foundation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. International study strengthens case for daily calcium pill
2. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
3. Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes
4. LCA Hails International Investigators Studying Lung Cancer
5. Arrow International Urges Shareholders To Vote for Approval of the $45.50 Teleflex Inc. Merger and for the Current Board of Directors
6. PRA International Adds Dr. Susan Stansfield as Executive Vice President
7. Medical Services International Maintains Pace in Second Quarter
8. Clarity Imaging International, Inc. Rolls Out Mobile DEXA Program
9. International Gateway Insurance Brokers Partners With MEDILINQ
10. Tulane University to receive $14M for international HIV/AIDS program
11. International Database Seeks to Boost Treatment of Altitude Sickness
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2017)... ... July 24, 2017 , ... Summer storms are inevitable ... havoc across communities and often result in massive tree damage requiring emergency tree service. ... take now including tree trimming, tree cabling and hazardous tree removal. , ...
(Date:7/24/2017)... VA (PRWEB) , ... July 24, 2017 , ... ... out how to change manufacturers future. , The agency is hammering out a ... Act, one of the farthest-ranging laws ever to affect FDA-regulated firms. The new ...
(Date:7/24/2017)... Long Island (PRWEB) , ... July 24, 2017 ... ... of a new office at 2307 Bellmore Avenue, Bellmore, New York, (516) 784-5858. ... dermatologist Jordan Fabrikant, M.D. and physician assistants Lori Friedman and Fruma Leah Wiederman. ...
(Date:7/24/2017)... ... July 24, 2017 , ... “Nana Nana Boo Boo”: ... of being kind to others. “Nana Nana Boo Boo” is the creation of published ... , Published by Christian Faith Publishing, Michael Rush’s new book presents the importance ...
(Date:7/24/2017)... ... , ... “Journey to the Light: The Quest for Happiness and Love. . ... to finding herself. “Journey to the Light: The Quest for Happiness and Love. ... writer of newsletters, manuals, and articles, who has recently decided to expand her literary ...
Breaking Medicine News(10 mins):
(Date:7/10/2017)... S.C. , July 10, 2017  BDI ... purchasing and patient support services organization serving specialty ... today the launch of four significant, value-added member ... market insights, better manage reimbursement and improve access ... and factor therapies. ...
(Date:7/5/2017)... 5, 2017 Oramed Pharmaceuticals Inc. ... ), a clinical-stage pharmaceutical company focused on the development ... received approval from the Israel Securities Authority to dual-list its ... common stock will commence trading on the TASE on July ... market capitalization of the Company, it is expected that Oramed ...
(Date:6/30/2017)... -- AVACEN Medical (AVACEN) announced the publication of new research in the ... its AVACEN Treatment Method to significantly reduce the widespread ... ... ... approximately 200 to 400 million people worldwide according to The National ...
Breaking Medicine Technology: